Why are physicians reluctant to use estrogens for anything – or do they prefer ‘PROFOX’?

Menopause International

Volumn 15, Issue 2, 2009, Pages 52-54

  Studd, John ^a  

^a London PMS and Menopause Clinic   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTIDEPRESSANT AGENT; BISPHOSPHONIC ACID DERIVATIVE; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ESTRADIOL; ESTROGEN; FLUOXETINE; GESTAGEN; MOOD STABILIZER; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE;

AGE DISTRIBUTION; BONE DENSITY; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FATIGUE; FEMUR FRACTURE; FRAGILITY FRACTURE; HEARTBURN; HIP FRACTURE; HORMONE RESPONSE; HOT FLUSH; HUMAN; HYPERTENSION; INVOLUTIONAL DEPRESSION; JAW OSTEONECROSIS; LIBIDO DISORDER; LONG TERM CARE; MEDICAL PRACTICE; MENOPAUSAL SYNDROME; OSTEOPOROSIS; PERIMENOPAUSAL DEPRESSION; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PREMENSTRUAL DEPRESSION; PREMENSTRUAL SYNDROME; PRESCRIPTION; PUERPERAL DEPRESSION; SHORT SURVEY; TREATMENT FAILURE; VAGINAL DRYNESS; VASOMOTOR DISORDER; WOMEN'S HEALTH;

ALENDRONATE; ATTITUDE OF HEALTH PERSONNEL; BONE DENSITY CONSERVATION AGENTS; DEPRESSION; ENGLAND; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FLUOXETINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PHYSICIAN'S PRACTICE PATTERNS; SOCIETIES, MEDICAL; WOMEN'S HEALTH;

EID: 67649973525     PISSN: 17540453     EISSN: 17540461     Source Type: Journal    
DOI: 10.1258/mi.2009.009019     Document Type: Editorial

References (16)

1. Williams LJ, Pasco JA, Jacko FN, Henry MJ, Dodd S, Berk M. Depression and bone metabolism. A review. Psychother Psychom 2009; 78: 16–25
2. Vestergaard P, Rejnmark L, Mosekinlde J. Anxiiolytics, antidepressants and the risk of fracture. Osteoporos Int 2006; 17: 807–16
3. Studd J, Panay N. Hormones and depression in women. Climacteric 2004; 4: 338–46
4. Gregoire A, Kumar R, Everitt B, Henderson AF, Studd JW. Transdermal oestrogen treatment of severe postnatal depression. Lancet 1996; 347: 930–933
5. Watson NR, Studd JW, Savvas M, Garnett T, Baber RJ. Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone. Lancet 1989; 2: 730–732
6. Montgomery JC, Appleby L, Brincat M,, et al. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987; 1: 297–299
7. Schmidt PJ. Mood, depression, and reproductive hormones in the menopausal transition. Am J Med 2005; 118(Supplement 12B):54–8
8. Khastgir G, Studd JWW, Holland N. Anabolic effect of long-term estrogen replacement on bone collagen in elderly postmenopausal women with osteoporosis. Osteoporos Int 2001; 12: 465–70
9. Muscat Baron Y, Brincat M, Galea R, Calleja N. Low intervertebral disc height in postmenopausal women with osteoporotic vertebral fractures compared to hormone-treated and untreated postmenopausal women and premenopausal women without fractures. Climacteric 2007; 7: 314–319
10. Studd JW. Estrogens should be first choice in the prevention and treatment of osteoporosis in women under the age of 60. Climacteric 2009; in press
11. Basu N, Reid DM. Bisphosphonate-associated osteonecrosis of the jaw. Menopause Int 2007; 13: 56–59
12. Weinstein RS, Roberson PK, Manolagas SC. Giant osteoclast formation and long-term oral bisphosphonate therapy. N Engl J Med 2009; 360: 53–62
13. Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD. Use of proton pump inhibitors and risk of osteoporosis-related fractures. CMAJ 2008; 179: 319–26
14. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H. Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701–12
15. Studd J. Hysterectomy–a life-saving as well as a life-enhancing operation. Menopause Int 2009; 15: 2–3
16. Stevenson JC. Hormone replacement therapy and cardiovascular disease revisited. Menopause Int 2009; 15: 55–57